Your browser doesn't support javascript.
loading
Prevalence of antibiotic resistance in US hospitals.
Edelsberg, John; Weycker, Derek; Barron, Rich; Li, Xiaoyan; Wu, Hongsheng; Oster, Gerry; Badre, Sejal; Langeberg, Wendy J; Weber, David J.
Afiliação
  • Edelsberg J; Policy Analysis Inc. (PAI), Brookline, MA, USA.
  • Weycker D; Policy Analysis Inc. (PAI), Brookline, MA, USA. Electronic address: dweycker@pai2.com.
  • Barron R; Amgen Inc., Thousand Oaks, CA, USA.
  • Li X; Amgen Inc., Thousand Oaks, CA, USA.
  • Wu H; Policy Analysis Inc. (PAI), Brookline, MA, USA; Wentworth Institute of Technology, Department of Computer Science and Networking, Boston, MA, USA.
  • Oster G; Policy Analysis Inc. (PAI), Brookline, MA, USA.
  • Badre S; Amgen Inc., Thousand Oaks, CA, USA.
  • Langeberg WJ; Amgen Inc., Thousand Oaks, CA, USA.
  • Weber DJ; University of North Carolina at Chapel Hill, Schools of Medicine and Public Health, Chapel Hill, NC, USA.
Diagn Microbiol Infect Dis ; 78(3): 255-62, 2014 Mar.
Article em En | MEDLINE | ID: mdl-24360267
ABSTRACT
The percentage of isolates resistant to essential antibiotics among clinically significant bacterial pathogens was evaluated using data from 80089 qualifying admissions in 19 US hospitals (2007-2010). Percentage resistant was highest for the following pathogen/antibiotic pairs Enterococcus faecium/vancomycin (87.1% [95% CI 86.0-88.1] of 4024 isolates), Staphylococcus aureus/oxacillin-methicillin (56.8% [56.1-57.4] of 23477 isolates), S. aureus/clindamycin (39.7% [39.1-40.4] of 21133 isolates), Pseudomonas aeruginosa/fluoroquinolones (32.6% [31.8-33.5] of 10982 isolates), and Escherichia coli/fluoroquinolones (31.3% [30.8-31.8] of 30715 isolates). The percentage resistant was 3.9% (3.2-4.9) for E. faecium/daptomycin (n = 2029 isolates). While these results are consistent with those from earlier studies in many respects, the percentage of E. faecium isolates resistant to daptomycin, while still small, is higher than has been reported to date.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Positivas / Infecções por Bactérias Gram-Negativas / Farmacorresistência Bacteriana Múltipla Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Diagn Microbiol Infect Dis Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 3_ND Base de dados: MEDLINE Assunto principal: Infecções por Bactérias Gram-Positivas / Infecções por Bactérias Gram-Negativas / Farmacorresistência Bacteriana Múltipla Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Diagn Microbiol Infect Dis Ano de publicação: 2014 Tipo de documento: Article